TW201726658A - 難治型憂鬱症等之治療藥 - Google Patents

難治型憂鬱症等之治療藥 Download PDF

Info

Publication number
TW201726658A
TW201726658A TW105143450A TW105143450A TW201726658A TW 201726658 A TW201726658 A TW 201726658A TW 105143450 A TW105143450 A TW 105143450A TW 105143450 A TW105143450 A TW 105143450A TW 201726658 A TW201726658 A TW 201726658A
Authority
TW
Taiwan
Prior art keywords
group
depression
receptor
substituted
formula
Prior art date
Application number
TW105143450A
Other languages
English (en)
Chinese (zh)
Inventor
西川弘之
清水聡子
加藤太朗
三平和明
Original Assignee
大日本住友製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大日本住友製藥股份有限公司 filed Critical 大日本住友製藥股份有限公司
Publication of TW201726658A publication Critical patent/TW201726658A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW105143450A 2015-12-28 2016-12-27 難治型憂鬱症等之治療藥 TW201726658A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015256154A JP2019059672A (ja) 2015-12-28 2015-12-28 治療抵抗性うつ病等の治療薬

Publications (1)

Publication Number Publication Date
TW201726658A true TW201726658A (zh) 2017-08-01

Family

ID=59224943

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105143450A TW201726658A (zh) 2015-12-28 2016-12-27 難治型憂鬱症等之治療藥

Country Status (3)

Country Link
JP (1) JP2019059672A (ja)
TW (1) TW201726658A (ja)
WO (1) WO2017115815A1 (ja)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612884D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
US6559140B2 (en) * 2000-03-09 2003-05-06 Abbott Laboratories Cyclic and bicyclic diamino histamine-3 receptor antagonists
AU2011225095C1 (en) * 2010-03-11 2017-01-19 Sumitomo Dainippon Pharma Co., Ltd. N-Acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
JP5715605B2 (ja) * 2011-09-14 2015-05-07 大日本住友製薬株式会社 Ｎ−アシル環状アミン誘導体またはその医薬上許容される塩からなる医薬
TWI562991B (en) * 2012-04-23 2016-12-21 Otsuka Pharma Co Ltd Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same

Also Published As

Publication number Publication date
WO2017115815A1 (ja) 2017-07-06
JP2019059672A (ja) 2019-04-18

Similar Documents

Publication Publication Date Title
EP3564217B1 (en) P2x4 receptor antagonist
JP6630374B2 (ja) τリン酸化を阻害する方法
JP2011507835A (ja) α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用
CN102316732A (zh) 氮杂䓬并[4,5-b]吲哚以及使用方法
PL187769B1 (pl) Pochodna 2,4-diaminopirymidyny jako antagonista receptora dopaminergicznego D, kompozycja farmaceutyczna, sposób wytwarzania kompozycji farmaceutycznej, zastosowanie pochodnej 2,4-diaminopirymidyny,sposób wytwarzania pochodnej 2,4 diaminopirymidyny
JPWO2009022731A1 (ja) Ｐ２ｘ４受容体拮抗剤
RS59411B1 (sr) Derivati 2-hidroksi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etan-1-ona i srodna jedinjenja kao inhibitori sintaze masnih kiselina (fasn) za lečenje kancera
CN111757882A (zh) 用于治疗、减轻或预防与Tau聚集体相关的病症如阿尔茨海默病的1,3,4,5-四氢-2H-吡啶并[4,3-b]吲哚衍生物
JP2002030084A (ja) １−アザビシクロアルカン化合物およびその医薬用途
HUP0500350A2 (hu) Pszichiátriai és neurológiai rendellenességek kezelésére alkalmas 3-indol-származékok
EP3700891A1 (en) Aromatic sulfonamide derivatives for the treatment of ischemic stroke
JP6751161B2 (ja) フッ素含有トリアゾロピリジン系化合物、その製造方法、医薬組成物及び用途
EP3371174A1 (en) Indolin-2-one derivatives
TW202506104A (zh) 氘化有機化合物及其用途（一）
AU2010340745B2 (en) Sulfone compounds as 5-HT6 receptor ligands
CN110944630B (zh) 精神药剂及其用途
KR20250173578A (ko) Fgfr2/3 선택적 억제제, 약학 조성물 및 이의 용도
TW202204343A (zh) 經取代之３－苯氧基氮雜環丁烷－１－基－吡
CN112313230B (zh) 用于治疗、缓解或预防与Tau聚集体相关的病症的新型化合物
EP3810593A1 (en) Oga inhibitor compounds
FI82054C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara furo/3,2-c/pyridiner.
CZ2004156A3 (cs) Název neuveden
JP4557112B2 (ja) ベンゾオキサゾール誘導体及び該誘導体を有効成分として含む医薬
WO2006010968A1 (en) New aryloxy acetic acid amide derivatives
WO2014192868A1 (ja) 環状アミノメチルピリミジン誘導体